28
Figure 2. Taper Management — Outpatient
Decision to taper
Transition to longer-acting BZD
a
1. Estimate equivalent dose
2. Transition one dose at a time, over 1–2 weeks
3. Adjust dose based on patient response
Would the patient
benefit from
transitioning to a
longer-acting BZD?
YES
NO
No or mild withdrawal symptoms
Consider similar pace for next dose reduction
Engage in shared decision making process with the patient
(and care partner[s]) whenever possible
a
See Transitioning to a Longer-Acting Benzodiazepine
